EarningsQ3 2024 Earnings Report

ACADIA Pharmaceuticals (ACAD) Q3 2024 Earnings Report

0 Followers

MX:ACAD Q3 2024 EPS Results

Actual EPS$3.63

Consensus EPS$2.51

Beat/MissBeat by +$1.13

One Year Ago EPS-$7.26

Actual Revenue$4.55B

Expected Revenue$4.52B

Beat/MissBeat by +$28.53M

YoY Revenue Growth+18.28%

QuarterQ3 2024

Date11/06/2024

TimeAfter Close

Conference CallWednesday, November 6, 2024

MX:ACAD Upcoming Earnings

ACADIA Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:ACAD Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	3.60 / -	7.628	―
Aug 04, 2026	2026 (Q2)	1.23 / 3.27	2.906	12.50% (+0.36)
May 06, 2026	2026 (Q1)	0.93 / 0.36	1.998	-81.82% (-1.63)
Feb 25, 2026	2025 (Q4)	2.49 / 29.06	15.619	86.05% (+13.44)
Nov 05, 2025	2025 (Q3)	3.14 / 7.63	3.632	110.00% (+4.00)
Aug 06, 2025	2025 (Q2)	2.51 / 2.91	3.632	-20.00% (-0.73)
May 07, 2025	2025 (Q1)	1.58 / 2.00	1.816	10.00% (+0.18)
Feb 26, 2025	2024 (Q4)	3.92 / 15.62	5.085	207.14% (+10.53)
Nov 06, 2024	2024 (Q3)	2.51 / 3.63	-7.265	150.00% (+10.90)
Aug 06, 2024	2024 (Q2)	3.23 / 3.63	0.182	1900.00% (+3.45)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed